3010 Phase, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): Subgroup analyses and patient reported outcomes (PROs)
Leora Horn, J. Brahmer, Martin Reck, Hossein Borghaei, David R. Spigel, Martin Steins, Neal Ready, Laura Q.M. Chow, E. Vokes, Enriqueta Felip, Esther Holgado, Fabrice Barlési, Martin Kohlhäufl, Marco Angelo Burgio, J. Fayette, Scott Gettinger, Christopher Harbison, A. Li, F. Graf Finckenstein, Luis Paz‐Ares
Cited by 7
Abstract
Related Papers
No related papers found
Powered by citation graph analysis